| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5729723 | European Urology Focus | 2016 | 8 Pages |
Abstract
Several biomarkers are currently under investigation that may predict which patients will respond to specific therapies in the future of metastatic castration-resistant prostate cancer treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Robert J. van Soest, Jason A. Efstathiou, Cora N. Sternberg, Bertand Tombal,